Adcetris 50 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBU4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,128
Award facts
- Contract value 100% obligated
- $72,127.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $72,127.76 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Adcetris 50 mg vials. The delivery order, issued on January 6, 2026, with an ultimate completion date of January 28, 2026, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative contract designated SPE2DR, which carries a $499.999 billion ceiling value and extends through December 31, 2036.
DMS Pharmaceutical Group serves as a critical regional pharmaceutical supplier within DLA's $30.3 billion PPV-G GEN V acquisition strategy, fulfilling diverse and specialized pharmaceutical requirements for Department of Defense military healthcare facilities worldwide. The company's established track record includes supplying oncology treatments, biologics, vaccines, specialty pharmaceuticals, and medical consumables across multiple therapeutic categories. As the sole prime contractor on this delivery order with no identified subcontractors, DMS Pharmaceutical Group's performance on this Adcetris supply order contributes to its operational role supporting recurring medical supply needs throughout the global military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FFBU4?
SPE2DR26FFBU4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FFBU4 worth?
The government has obligated $72,128 on SPE2DR26FFBU4.
Is contract SPE2DR26FFBU4 an order under another contract?
Yes. SPE2DR26FFBU4 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBU4 competed?
The extent of competition for SPE2DR26FFBU4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award